The antidiabetic and insulin nanocarriers employed for the management of diabetes mellitus comprise various types of nanoparticles and self-nanoemulsifying antidiabetic drug delivery systems [64,65,66,67,68,69]. This evidence concerns the gene INS and diabetes mellitus.